The North America Medical Aesthetics Market would witness market growth of 9.1% CAGR during the forecast period (2023-2030).
The general population's demand for facial aesthetics to enhance their appearance has increased in recent years. This has increased the demand for dermal filler procedures for treating wrinkles, acne scarring, and other conditions. To address the rising demand for dermal fillers in the medical aesthetics market, major industry players are also investing in R&D to develop innovative fillers. Acne, psoriasis, skin cancer, and other dermatological diseases are becoming more common among the general population in several countries. Due to a large patient population with severe skin problems requiring treatment, the market is experiencing a rising demand for innovative solutions.
Moreover, the availability of products at home is increasing the demand for dermatology conditions to be treated at home. The manufacturers are emphasizing the development and introduction of new home-use technologies, such as LED and radiofrequency-based devices, resulting in the increased adoption of home-based devices. The above factors and the patient adoption rate of innovative products for treatment and use at home further drive market expansion.
According to International Society of Aesthetic Plastic Surgery (ISAPS)’ International Survey on Aesthetic/Cosmetic Procedures 2022, the total number of breast surgeries in the US was 555,522. Many hospitals in the U.S. have dedicated departments or facilities for medical aesthetics. These facilities offer a wide range of aesthetic treatments, including surgical and non-surgical ones. Due to these aspects, the market will grow in upcoming years.
The US market dominated the North America Medical Aesthetics Market by Country in 2022; and would continue to be a dominant market till 2030, thereby, achieving a market value of $7,777.4 million by 2030. The Canada market is experiencing a CAGR of 11.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.6% during (2023 - 2030).
Based on End User, the market is segmented into Clinics, Hospitals, & Medicals Spas, Beauty Centres, & Home Care Settings. Based on Procedure, the market is segmented into Non-Surgical Procedures (Anti-Aging And Skin Rejuvenation, Tattoo & Scar Removal, Hair Removal, Lipolysis, Others), & Surgical Procedures (Breast Augmentation, Facelift & Body Lift, Rhinoplasty, Others). Based on Product, the market is segmented into Facial Aesthetic Products, Body Contouring Devices, Hair Removal Devices, Physician-dispensed cosmeceuticals And Skin Lighteners, Cosmetics Implant, Skin Aesthetic Devices, Tattoo Removal Devices, & Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Medical Aesthetics Market is Predict to reach $31.1 Billion by 2030, at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (AbbVie, Inc.), Alma Lasers Ltd. (Sisram Medical Ltd.), Bausch Health Companies Inc, Anika Therapeutics, Inc, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Candela corporation, Lumenis Be Ltd., Galderma S.A., and Cutera, Inc.
By End User
By Procedure
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 